Completed OBSERVATIONAL NCT00005327

Prevention of Cerebral Infarction in Sickle Cell Anemia - Comprehensive Sickle Cell Center

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Anemia, Sickle Cell Blood Disease Cerebrovascular Accident Cerebrovascular Disorders

Updated 7 times since 2017 Last updated: Jul 2, 2019 Started: Apr 30, 1993 Primary completion: Mar 31, 1998 Completion: Mar 31, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00005327, this observational or N/A phase trial focuses on Anemia, Sickle Cell and Blood Disease and remains completed. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 7 times since 1993, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Aug 2019 — Jan 2021 [monthly]

Completed
Jun 2018 — Aug 2019 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Apr 1993

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Heart, Lung, and Blood Institute (NHLBI)
University of Southern California

Data source: University of Southern California

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.